ELECSYS BRAHMS PCT 05056888200

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-01-26 for ELECSYS BRAHMS PCT 05056888200 manufactured by Roche Diagnostics.

Event Text Entries

[65849398] (b)(4). This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[65849399] The customer received questionable results for elecsys ft4 ii assay, elecsys vitamin b12 immunoassay, elecsys folate iii assay, elecsys brahms pct, and elecsys tsh assay for one patient and suspected an interference with biotin from the qizenday treatment the patient was receiving. The customer used a cobas 6000 e 601 module. The serial number was requested but was not provided. Specific data and additional information for the complaint was requested but was not provided. Information concerning if any erroneous result was reported outside the laboratory was requested but it was unknown. The patient was not adversely affected. The complaint also involved elecsys ft4 ii assay, elecsys vitamin b12 immunoassay, elecsys folate iii assay, and elecsys tsh assay. Refer to the medwatchs with patient identifiers (b)(6) for the other assays involved.
Patient Sequence No: 1, Text Type: D, B5


[68234382] (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[68624348] The units of measure for the assays involved in this event were provided as follows: ft4: pmol / l. B12: pg / ml. Fol: nmol / l. Pct: ng / ml. Tsh: mu / l. Samples drawn from the patient on (b)(6) 2017, (b)(6) 2017, 01/12/2017, (b)(6) 2017, and (b)(6) 2017 were submitted for investigation. The samples were tested on a cobas e601 analyzer and a cobas e411 analyzer. Based on the results for four of the samples, an immunoglobulin that reacts with the reagent and affects the results was suspected. No interfering factor to streptavidin was found in the samples.
Patient Sequence No: 1, Text Type: N, H10


[71153733] The biotin concentration was measured in the samples provided: (b)(6). For all of the samples drawn when the patent was known to be taking the qizenday treatment, the result was higher than the allowable concentrations specified in the method sheets of all involved assays. The result for the sample from (b)(6) 2017 when the patient may have not been taking the qizenday treatment was not above the allowable concentrations. The high biotin concentration most likely caused the issue. Interference with assays that use the biotin-streptavidin technology is possible and the therapy should be stopped for one week before measurements are done.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2017-00158
MDR Report Key6280280
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-01-26
Date of Report2017-03-20
Date of Event2017-01-02
Date Mfgr Received2017-01-05
Date Added to Maude2017-01-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Sequence Number: 0

Brand NameELECSYS BRAHMS PCT
Generic NameDEVICE TO DETECT AND MEASURE PROCALCITONIN
Product CodeJLW
Date Received2017-01-26
Model NumberNA
Catalog Number05056888200
Lot NumberASKU
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No0
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457

Device Sequence Number: 1

Brand NameELECSYS BRAHMS PCT
Generic NameDEVICE TO DETECT AND MEASURE PROCALCITONIN
Product CodePMT
Date Received2017-01-26
Model NumberNA
Catalog Number05056888200
Lot NumberASKU
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-01-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.